---
title: Clonazepam + Paroxetine
description: >-
  This combination is not typically prescribed together as a first-line
  treatment.  Clonazepam and Paroxetine are prescribed for different conditions,
  although there may be some overlap. Clonazepam is indicated for certain
  seizure disorders (such as Lennox-Gastaut syndrome, akinetic, myoclonic,
  and...
is_banned: false
lastModified: '2025-09-22T17:22:08.865Z'
faqs:
  - q: >-
      What is the recommended dosage for Clonazepam + Paroxetine?**

      **A:** There is no standard recommended dosage for this combination.  The
      drugs are typically dosed individually based on the specific indication
      and patient factors.
    a: >-
      A:** There is no standard recommended dosage for this combination.  The
      drugs are typically dosed individually based on the specific indication
      and patient factors.
  - q: >-
      What are the common side effects of combining these drugs?**

      **A:** Increased risk of drowsiness, dizziness, cognitive impairment, and
      serotonin syndrome.
    a: >-
      A:** Increased risk of drowsiness, dizziness, cognitive impairment, and
      serotonin syndrome.
  - q: >-
      Can this combination be used during pregnancy?**

      **A:**  Both drugs carry risks during pregnancy and should be used only if
      the benefits clearly outweigh the risks. Consult with a specialist.
    a: >-
      A:**  Both drugs carry risks during pregnancy and should be used only if
      the benefits clearly outweigh the risks. Consult with a specialist.
  - q: >-
      Are there any specific monitoring parameters for this combination?**

      **A:**  Monitor for signs of CNS depression, serotonin syndrome, and
      adverse effects specific to each drug.
    a: >-
      A:**  Monitor for signs of CNS depression, serotonin syndrome, and adverse
      effects specific to each drug.
  - q: >-
      What are the contraindications for using this combination?**

      **A:**  Contraindications include hypersensitivity to either drug, severe
      respiratory insufficiency (clonazepam), acute narrow-angle glaucoma
      (clonazepam), and concurrent use with MAOIs (paroxetine).
    a: >-
      A:**  Contraindications include hypersensitivity to either drug, severe
      respiratory insufficiency (clonazepam), acute narrow-angle glaucoma
      (clonazepam), and concurrent use with MAOIs (paroxetine).
  - q: >-
      What are the key drug interactions to be aware of?**

      **A:**  Both drugs have numerous drug interactions. Clinically significant
      interactions include alcohol, opioids, other CNS depressants (clonazepam),
      MAOIs, CYP2D6 inhibitors, serotonergic drugs, anticoagulants, and NSAIDs
      (paroxetine).
    a: >-
      A:**  Both drugs have numerous drug interactions. Clinically significant
      interactions include alcohol, opioids, other CNS depressants (clonazepam),
      MAOIs, CYP2D6 inhibitors, serotonergic drugs, anticoagulants, and NSAIDs
      (paroxetine).
  - q: >-
      How is this combination metabolized and eliminated?**

      **A:**  Clonazepam is metabolized primarily by CYP3A4 and excreted
      renally. Paroxetine is metabolized primarily by CYP2D6 and excreted in
      urine and feces.
    a: >-
      A:**  Clonazepam is metabolized primarily by CYP3A4 and excreted renally.
      Paroxetine is metabolized primarily by CYP2D6 and excreted in urine and
      feces.
  - q: >-
      Are there any alternative treatments available?**

      **A:** Alternative treatments depend on the specific indication.  Discuss
      alternative options with a specialist.
    a: >-
      A:** Alternative treatments depend on the specific indication.  Discuss
      alternative options with a specialist.
  - q: >-
      Can this combination be used in elderly patients?**

      **A:** Use with caution in the elderly; lower starting doses and slower
      titration are recommended for both medications due to age-related changes
      in drug metabolism and clearance.
    a: >-
      A:** Use with caution in the elderly; lower starting doses and slower
      titration are recommended for both medications due to age-related changes
      in drug metabolism and clearance.
---
## **Usage**

This combination is not typically prescribed together as a first-line treatment.  Clonazepam and Paroxetine are prescribed for different conditions, although there may be some overlap. Clonazepam is indicated for certain seizure disorders (such as Lennox-Gastaut syndrome, akinetic, myoclonic, and absence seizures) and panic disorder. Paroxetine is indicated for major depressive disorder, obsessive-compulsive disorder (OCD), panic disorder, social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder (PTSD).

**Pharmacological Classifications:**

* **Clonazepam:** Benzodiazepine (Anxiolytic, Anticonvulsant, Sedative)
* **Paroxetine:** Selective Serotonin Reuptake Inhibitor (SSRI) (Antidepressant)

**Mechanism of Action:**

* **Clonazepam:** Enhances the effect of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in the central nervous system, leading to decreased neuronal excitability.
* **Paroxetine:** Inhibits the reuptake of serotonin in the synaptic cleft, increasing serotonin availability.

## **Alternate Names**

* **Clonazepam:** Klonopin (brand name), Rivotril (brand name)
* **Paroxetine:** Paxil (brand name), Paxil CR (brand name), Brisdelle (brand name), Pexeva (brand name)

## **How It Works**

**Clonazepam:**

* **Pharmacodynamics:** Reduces neuronal excitability by potentiating GABAergic neurotransmission.
* **Pharmacokinetics:** Well-absorbed orally, metabolized in the liver (primarily by CYP3A4), and excreted mainly in urine.
* **Mode of Action:** Binds to the benzodiazepine site on the GABA-A receptor complex, increasing the frequency of chloride channel opening, leading to hyperpolarization and reduced neuronal firing.
* **Elimination:** Primarily hepatic metabolism, renal excretion.

**Paroxetine:**

* **Pharmacodynamics:** Enhances serotonergic neurotransmission by inhibiting serotonin reuptake.
* **Pharmacokinetics:** Well-absorbed orally, extensively metabolized in the liver (primarily by CYP2D6), and excreted in urine and feces.
* **Mode of Action:** Selectively inhibits the serotonin transporter (SERT), increasing serotonin levels in the synaptic cleft.
* **Elimination:** Primarily hepatic metabolism, renal and fecal excretion.



## **Dosage**

This combination requires careful consideration due to potential drug interactions and overlapping side effects. Dosing should be individualized based on patient response and clinical judgment.  The dosages below are for each drug individually and should not be interpreted as a combined dosage recommendation.

### **Standard Dosage**

#### **Adults: Clonazepam**

* **Seizures:** Initially 0.5 mg three times daily, increasing by 0.5-1 mg every 3 days as needed, up to a maximum of 20 mg/day.
* **Panic Disorder:** Initially 0.25 mg twice daily, increasing to 1 mg/day after 3 days as needed, up to a maximum of 4 mg/day.

#### **Adults: Paroxetine**

* **Most Indications:** Initially 20 mg once daily, may increase by 10 mg weekly as needed.
* **Maximum doses vary by indication (see sources)**

#### **Children: Clonazepam**

* Based on body weight (0.01-0.03 mg/kg/day divided into 2-3 doses), not to exceed 0.05 mg/kg/day initially or 0.2 mg/kg/day maintenance.

#### **Children: Paroxetine**

* Not typically recommended, use with caution under specialist supervision.

#### **Special Cases:**

* **Elderly Patients:** Lower starting doses and slower titration are recommended for both medications.
* **Patients with Renal Impairment:** Dose adjustments may be needed for both medications.
* **Patients with Hepatic Dysfunction:** Dose adjustments may be needed for both medications.
* **Patients with Comorbid Conditions:** Careful monitoring is essential.

### **Clinical Use Cases**

The combined use of these drugs is not generally recommended for the clinical use cases listed below.  This information applies to each medication individually.

* **Intubation/Surgical Procedures/Mechanical Ventilation/ICU Use/Emergency Situations:** Clonazepam may be used for sedation or seizure control.  Paroxetine is not typically used in these settings.


### **Dosage Adjustments**

Adjustments are based on patient response, tolerability, and renal/hepatic function.  Therapeutic drug monitoring may be helpful.

## **Side Effects**

### **Common Side Effects**

* **Clonazepam:** Drowsiness, dizziness, fatigue, ataxia.
* **Paroxetine:** Nausea, insomnia, somnolence, dizziness, headache, dry mouth, constipation, sexual dysfunction.

### **Rare but Serious Side Effects**

* **Clonazepam:** Respiratory depression, dependence.
* **Paroxetine:** Serotonin syndrome, suicidal ideation (especially in young adults), bleeding disorders, hyponatremia.

### **Long-Term Effects**

* **Clonazepam:** Tolerance, dependence.
* **Paroxetine:**  Sexual dysfunction, weight gain.

### **Adverse Drug Reactions (ADR)**

* **Clonazepam:** Angioedema, Stevens-Johnson syndrome.
* **Paroxetine:**  Neuroleptic malignant syndrome, serotonin syndrome.

## **Contraindications**

* **Clonazepam:** Hypersensitivity to benzodiazepines, severe respiratory insufficiency, acute narrow-angle glaucoma.
* **Paroxetine:** Hypersensitivity to SSRIs, concurrent use with MAOIs.


## **Drug Interactions**

Both medications interact with numerous drugs.  Clinically significant interactions include:

* **Clonazepam:** Alcohol, opioids, other CNS depressants.
* **Paroxetine:** MAOIs,  CYP2D6 inhibitors, serotonergic drugs, anticoagulants, NSAIDs.
* **Combined use:** Increased risk of CNS depression and serotonin syndrome.

## **Pregnancy and Breastfeeding**

* **Clonazepam:** Use with caution; potential for neonatal withdrawal syndrome.
* **Paroxetine:** Use with caution; potential for fetal cardiac defects and persistent pulmonary hypertension of the newborn (PPHN).

## **Drug Profile Summary** (See individual sections above)

## **Popular Combinations**  (Not applicable for this specific combined usage)

## **Precautions** (See individual sections above)

## **FAQs**

### **Q1: What is the recommended dosage for Clonazepam + Paroxetine?**
**A:** There is no standard recommended dosage for this combination.  The drugs are typically dosed individually based on the specific indication and patient factors.

### **Q2: What are the common side effects of combining these drugs?**
**A:** Increased risk of drowsiness, dizziness, cognitive impairment, and serotonin syndrome.

### **Q3:  Can this combination be used during pregnancy?**
**A:**  Both drugs carry risks during pregnancy and should be used only if the benefits clearly outweigh the risks. Consult with a specialist.

### **Q4: Are there any specific monitoring parameters for this combination?**
**A:**  Monitor for signs of CNS depression, serotonin syndrome, and adverse effects specific to each drug.

### **Q5: What are the contraindications for using this combination?**
**A:**  Contraindications include hypersensitivity to either drug, severe respiratory insufficiency (clonazepam), acute narrow-angle glaucoma (clonazepam), and concurrent use with MAOIs (paroxetine).

### **Q6: What are the key drug interactions to be aware of?**
**A:**  Both drugs have numerous drug interactions. Clinically significant interactions include alcohol, opioids, other CNS depressants (clonazepam), MAOIs, CYP2D6 inhibitors, serotonergic drugs, anticoagulants, and NSAIDs (paroxetine).

### **Q7: How is this combination metabolized and eliminated?**
**A:**  Clonazepam is metabolized primarily by CYP3A4 and excreted renally. Paroxetine is metabolized primarily by CYP2D6 and excreted in urine and feces.

### **Q8: Are there any alternative treatments available?**
**A:** Alternative treatments depend on the specific indication.  Discuss alternative options with a specialist.

### **Q9:  Can this combination be used in elderly patients?**
**A:** Use with caution in the elderly; lower starting doses and slower titration are recommended for both medications due to age-related changes in drug metabolism and clearance.



